SU620206A3 - Способ получени производных оксима или их солей - Google Patents
Способ получени производных оксима или их солейInfo
- Publication number
- SU620206A3 SU620206A3 SU772503815A SU2503815A SU620206A3 SU 620206 A3 SU620206 A3 SU 620206A3 SU 772503815 A SU772503815 A SU 772503815A SU 2503815 A SU2503815 A SU 2503815A SU 620206 A3 SU620206 A3 SU 620206A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- oxime
- compound
- salts
- mmol
- ethanol
- Prior art date
Links
- 150000002923 oximes Chemical class 0.000 title claims 12
- 150000003839 salts Chemical class 0.000 title claims 8
- 238000000034 method Methods 0.000 title claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 229910021529 ammonia Inorganic materials 0.000 claims 3
- -1 cyanomethy Chemical group 0.000 claims 3
- 239000012442 inert solvent Substances 0.000 claims 3
- 238000003756 stirring Methods 0.000 claims 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- 125000005905 mesyloxy group Chemical group 0.000 claims 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 2
- 235000011152 sodium sulphate Nutrition 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical group 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 239000000571 coke Substances 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003480 eluent Substances 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000005457 ice water Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 239000011976 maleic acid Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
- C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (1)
- Изобретение относитс к способу получени НОВЫХ) не описанных в литературе производных оксима или их солей, которые обладают биологической активностью и мо гут найти применение в медицине. В литературе широко описано получение производных оксима путем взаимодействи тозилпровзводных оксима с аммиаком ij Целью; изобретени вл етс разработка способа получени новых производных оксима или их солей, которые обладают высокой биологической активностью. Согласно изобретению предлагаетс способ получени производных оксима обшей формулы I 1:, М-0-6Н2-Ш2-КНа 1ен2)з-11 где R i циано-, цианомети -, метоксимети/ь- или этоксиметил, или их солей, заключающийс в том, что соединение обшей формулы Ц : N - о - СН.2 - Н2-Т 1 ( LHa)3-TR имеет указанные значени , - мезилокси- или тозилокси- группа, подвергают взаимодействию с избырком аммиака в инертном растворителе, таком как спирт, при температуре от кок натной до 150°С с последующим выделением целевого продукта в свободном виде или в виде соли. Свободное соединение обшей формулы 1 перевод т в соль, использу дл этого такие кислоты, как сол$шую или малеиновую . Исходное соединение формулы ( мо &но получать обработкой соединени форму1Ы Ш р , / Ч-й N-О-М (СНг) где R имеет указанные значени , М - водород или атом щелочного металла, окисью этилена в этаноле в гфисутствии алкогол та при температуре до 60°С Затем продукт реакции переводш с помощью тозилхлорида или мезилхлорида в ио ходное соединение формулы И в инерт ном растворителе, например метиленхлс риде . Пример. Малеат (1:1) б-мет окси- 4-трифторметилвалерофенон-О-( 2- ««мин оэтил)-оксима, а)26 ммолей (1,15 г) окиси этилена подают в суспензию 15,5 ммолей (4,Зг) 5-мето сси-4-трифторметилвалерофеноноксима (т. Ш1. 41,5-43,5°СУ в 25 мл а солютного этанола.в котором сначала раствор ют 0,003 г металлического лити при перемешивании при 55°С с помощью тока азота. Затем перемешивают еще 1 час при 60 С. После добавлени О,3 мл уксусной кислоты этанол отгон ют в вакууме и остаток очищают хроматографически на силикагеле , примен в качестве элю ента. После отгонки растворител получак т в виде масла О-(2-оксиэтил)-оксим. б)2,23 мл триэтиламина добавл ют к раствору 11 ммолей (3,6 г) указанного оксима в 60 мл метиленхлорида при перемешивании при -5 - 0°С, затем добавл ют 12 ммолей (0,9 мл) мезилхлорида по капл м около 20 мин. Перемешивание про- должают при 0°С еще ЗО мин, затем смес последовательно промывают лед ной водой (4 раза), 5%-ным раствором бикарбоната натри при 0°С (1 раз) и насыщенным раствором NaCfc (2 раза). После сушки над сульфатом натри при 5°С отгон ют в вакууме при температуре бани : 4О-60°С. Таким образом получают О.(2«-мезилоксиэтил )-оксим. в)Смесь 8 ммолей (3,2 г) этого окСима в ЗО мл метанола, содержащего 233 мм ОЛЯ (4,0 г) flHj вьздерживают при в автоклаве 16 час. После охлаждени метанол отгон ют в вакуум, остаток перемешивают с 50 мл 2 н.раст вора едкого натра и экстрагируют эфиром. Эфирный слой промывают 59fe-ным раствором бикарбоната натри . -После сушки на сульфате натри и отгонки эфира в вакууме остаток раствор ют в абсолютном этаноле, к которому добавл ют эквимол рное количество малеиновой кислоты. Этанол отгон ют в вакууме н остаток смывают ацетонитрилом, из которого перекристаллизовывают целевое соединение. Формула изобретени Способ получени производных оксима общей формулы Ч.с -0-б11г- Нг- Кг .( )з - R где R - циано-, цианометил-, метоксиметил- или этоксиметилгруппа, или их солей, отличающийс тем, что соединение общей формулы о- -Bi ( .Нг)з-11 где R имеет указанные значени , R - мезилокси- или тозилоксигруппа, подвергают вза1|модействию с избытком аммиака в инертном растворителе, таком как спир, при температуре от комнатной до 150 С с последующим выделением целевого продукта в свободном виде или в виде соли. Источники информации, прин тые во нимание при экспертизе: 1. Патент Англии № 1205655; л. С(2)С, 197О.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7503310A NL7503310A (nl) | 1975-03-20 | 1975-03-20 | Verbindingen met antidepressieve werking. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU620206A3 true SU620206A3 (ru) | 1978-08-15 |
Family
ID=19823424
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU762335241A SU635867A3 (ru) | 1975-03-20 | 1976-03-17 | Способ получени производных оксима или их солей |
| SU772503815A SU620206A3 (ru) | 1975-03-20 | 1977-07-12 | Способ получени производных оксима или их солей |
| SU772503814A SU645559A3 (ru) | 1975-03-20 | 1977-07-12 | Способ получени производных оксима или их солей |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU762335241A SU635867A3 (ru) | 1975-03-20 | 1976-03-17 | Способ получени производных оксима или их солей |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU772503814A SU645559A3 (ru) | 1975-03-20 | 1977-07-12 | Способ получени производных оксима или их солей |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4085225A (ru) |
| JP (1) | JPS6026776B2 (ru) |
| AR (2) | AR211011A1 (ru) |
| AT (1) | AT340895B (ru) |
| AU (1) | AU505358B2 (ru) |
| BE (1) | BE839744A (ru) |
| CA (1) | CA1076142A (ru) |
| CH (4) | CH626057A5 (ru) |
| DD (1) | DD128332A5 (ru) |
| DE (1) | DE2610886A1 (ru) |
| DK (1) | DK144942C (ru) |
| ES (1) | ES446192A1 (ru) |
| FI (1) | FI61875C (ru) |
| FR (1) | FR2304336A1 (ru) |
| GB (1) | GB1535226A (ru) |
| GR (1) | GR60052B (ru) |
| HU (1) | HU171030B (ru) |
| IE (1) | IE43768B1 (ru) |
| IL (1) | IL49238A (ru) |
| IT (1) | IT1063064B (ru) |
| MX (1) | MX9203723A (ru) |
| NL (1) | NL7503310A (ru) |
| PL (3) | PL101951B1 (ru) |
| SE (1) | SE410312B (ru) |
| SU (3) | SU635867A3 (ru) |
| YU (1) | YU39345B (ru) |
| ZA (1) | ZA761434B (ru) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1110460B (it) * | 1977-03-02 | 1985-12-23 | Ciba Geigy Ag | Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego |
| FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US5665756A (en) * | 1994-08-03 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
| US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| WO1997006792A1 (en) * | 1995-08-16 | 1997-02-27 | Eli Lilly And Company | Potentiation of serotonin response |
| IN182588B (ru) | 1998-05-12 | 1999-05-08 | Sun Pharmaceutical Ind Ltd | |
| IE990406A1 (en) | 1999-05-20 | 2000-12-27 | Elan Corp Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. |
| IN186677B (ru) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
| AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| US20080021085A1 (en) * | 2000-04-13 | 2008-01-24 | Mayo Foundation For Medical Education And Research | Method of reducing abeta42 and treating diseases |
| EP1276478A2 (en) | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | (2-aminoethyl) oxime derivatives for the treatment of depression |
| US7256191B2 (en) * | 2000-04-24 | 2007-08-14 | Aryx Therapeutics | Materials and methods for the treatment of depression |
| NZ532033A (en) * | 2001-10-12 | 2006-11-30 | Azevan Pharmaceuticals Inc | 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives as vasopressin V1a receptor antagonists |
| IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
| WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
| CA2532207A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| DE602004024317D1 (de) | 2003-09-12 | 2010-01-07 | Pfizer | Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern |
| US7671072B2 (en) * | 2003-11-26 | 2010-03-02 | Pfizer Inc. | Aminopyrazole derivatives as GSK-3 inhibitors |
| WO2005060968A1 (en) | 2003-12-11 | 2005-07-07 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
| CA2567249A1 (en) * | 2004-04-19 | 2006-10-05 | Jds Pharmaceuticals, Llc | Lithium combinations, and uses related thereto |
| MXPA06012165A (es) * | 2004-04-29 | 2007-01-17 | Keystone Retaining Wall System | Chapas para muros, muros de contencion y similares. |
| BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
| WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
| EP1868434A4 (en) | 2005-03-22 | 2011-10-26 | Azevan Pharmaceuticals Inc | BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS |
| AU2006239942A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
| AU2006239897A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| AU2006239920A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
| JP2008538573A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ベンゾフラニルアルカナミン誘導体およびその5−ht2cアゴニストとしての使用 |
| US20070015138A1 (en) * | 2005-07-08 | 2007-01-18 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
| US20070015832A1 (en) * | 2005-07-14 | 2007-01-18 | Myriad Genetics, Incorporated | Methods of treating overactive bladder and urinary incontinence |
| TR201907381T4 (tr) | 2005-07-19 | 2019-06-21 | Azevan Pharmaceuticals Inc | Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti. |
| KR20080039876A (ko) * | 2005-07-22 | 2008-05-07 | 미리어드 제네틱스, 인크. | 높은 약물 충진 제형 및 투여형 |
| US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| CN101410112A (zh) * | 2006-03-24 | 2009-04-15 | 惠氏公司 | 治疗抑郁症的新治疗组合 |
| JP4615470B2 (ja) * | 2006-03-29 | 2011-01-19 | 卓郎 簑和田 | 大脳の認知力を用いた疾患治療・予防の方法および医薬 |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| EP2046119A2 (en) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
| TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100016274A1 (en) * | 2006-09-14 | 2010-01-21 | Koppel Gary A | Beta-lactam cannabinoid receptor modulators |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
| EP2125017A2 (en) * | 2007-01-11 | 2009-12-02 | Braincells, Inc. | Modulation of neurogenesis with use of modafinil |
| US20110034565A1 (en) | 2008-04-18 | 2011-02-10 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
| WO2010021681A2 (en) * | 2008-08-18 | 2010-02-25 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| ES2585806T3 (es) | 2009-10-23 | 2016-10-10 | Janssen Pharmaceutica N.V. | Octahidropirrolo [3,4-c] pirroles disustituidos como moduladores de receptores de orexina |
| EP2509596B1 (en) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma aminoacids for treating ocular disorders |
| ES2662350T3 (es) | 2010-07-01 | 2018-04-06 | Azevan Pharmaceuticals, Inc. | Procedimientos para el tratamiento del trastorno por estrés postraumático |
| US20140010883A1 (en) | 2011-03-17 | 2014-01-09 | Lupin Limited | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor |
| KR101427221B1 (ko) * | 2012-08-29 | 2014-08-13 | 주식회사 에스텍파마 | 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법 |
| US9783492B2 (en) | 2013-04-03 | 2017-10-10 | Zcl Chemicals Limited | Process for the preparation of fluvoxamine maleate |
| US10124006B2 (en) | 2014-02-07 | 2018-11-13 | MTA Tämogatott Kutatócsoportok Irodája | Use of Sigma-1 receptor agonist compounds |
| AU2015237253B2 (en) | 2014-03-28 | 2019-11-14 | Azevan Pharmaceuticals, Inc. | Compositions and methods for treating neurodegenerative diseases |
| HRP20220642T1 (hr) | 2016-03-10 | 2022-06-24 | Janssen Pharmaceutica Nv | Postupci za liječenje depresije uporabom antagonista receptora oreksina 2 |
| MA46898A (fr) | 2016-11-24 | 2019-10-02 | Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag | Compositions pour la conservation d'organes |
| MY208313A (en) | 2017-09-15 | 2025-04-30 | Azevan Pharmaceuticals Inc | Compositions and methods for treating brain injury |
| US20240024288A1 (en) | 2019-07-19 | 2024-01-25 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3692835A (en) * | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
-
1975
- 1975-03-20 NL NL7503310A patent/NL7503310A/xx not_active Application Discontinuation
-
1976
- 1976-03-09 ZA ZA761434A patent/ZA761434B/xx unknown
- 1976-03-16 DE DE19762610886 patent/DE2610886A1/de active Granted
- 1976-03-17 CH CH334576A patent/CH626057A5/de active Protection Beyond IP Right Term
- 1976-03-17 SE SE7603341A patent/SE410312B/xx not_active IP Right Cessation
- 1976-03-17 FI FI760699A patent/FI61875C/fi not_active IP Right Cessation
- 1976-03-17 HU HU76PI00000513A patent/HU171030B/hu unknown
- 1976-03-17 PL PL1976199557A patent/PL101951B1/pl unknown
- 1976-03-17 IT IT21320/76A patent/IT1063064B/it active Protection Beyond IP Right Term
- 1976-03-17 CA CA248,102A patent/CA1076142A/en not_active Expired
- 1976-03-17 DD DD7600191893A patent/DD128332A5/xx unknown
- 1976-03-17 DK DK115976A patent/DK144942C/da not_active IP Right Cessation
- 1976-03-17 SU SU762335241A patent/SU635867A3/ru active
- 1976-03-17 IL IL49238A patent/IL49238A/xx unknown
- 1976-03-17 PL PL1976199556A patent/PL100052B1/pl unknown
- 1976-03-17 GB GB10703/76A patent/GB1535226A/en not_active Expired
- 1976-03-17 PL PL1976188006A patent/PL100614B1/pl unknown
- 1976-03-17 AT AT195476A patent/AT340895B/de active Protection Beyond IP Right Term
- 1976-03-17 GR GR50333A patent/GR60052B/el unknown
- 1976-03-18 YU YU714/76A patent/YU39345B/xx unknown
- 1976-03-18 BE BE165316A patent/BE839744A/xx not_active IP Right Cessation
- 1976-03-18 AU AU12147/76A patent/AU505358B2/en not_active Expired
- 1976-03-18 ES ES446192A patent/ES446192A1/es not_active Expired
- 1976-03-18 IE IE567/76A patent/IE43768B1/en not_active IP Right Cessation
- 1976-03-19 US US05/668,461 patent/US4085225A/en not_active Expired - Lifetime
- 1976-03-19 JP JP51029394A patent/JPS6026776B2/ja not_active Expired
- 1976-03-19 FR FR7608019A patent/FR2304336A1/fr active Granted
- 1976-03-22 AR AR262650A patent/AR211011A1/es active
- 1976-12-10 AR AR265801A patent/AR211153A1/es active
-
1977
- 1977-07-12 SU SU772503815A patent/SU620206A3/ru active
- 1977-07-12 SU SU772503814A patent/SU645559A3/ru active
-
1981
- 1981-03-06 CH CH154081A patent/CH629477A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154181A patent/CH629761A5/de not_active IP Right Cessation
- 1981-03-06 CH CH153981A patent/CH629184A5/de not_active IP Right Cessation
-
1992
- 1992-06-29 MX MX9203723A patent/MX9203723A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU691089A3 (ru) | Способ получени карбонилзамещенных 1-сульфонилбензимидазолов | |
| Capozzi et al. | Phthalimidosulfenyl chloride. Part 5. Reaction with enolizable carbonyl compounds and synthesis of functionalized thiones. | |
| JPS6318588B2 (ru) | ||
| US4673761A (en) | Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives | |
| EP0285270B1 (en) | A method for producing 1-propargyl-2,4-dioxoimidazolidine | |
| EP0006355B1 (en) | Mixed anhydride steroid intermediate and process for preparing steroid intermediates | |
| CN116925023B (zh) | 2-全氟烷基-4h-吡喃-4-酮衍生物的改进合成方法 | |
| SU639448A3 (ru) | Способ получени производных оксима или их солей | |
| US4257949A (en) | Bisnoraldehyde-22-enamine process | |
| GB2036744A (en) | Eburnane derivatives | |
| US5654429A (en) | Method for the preparation of 3-amino-2-chloro-4-alkylpyridines | |
| KR900000266B1 (ko) | 아포빈캐미닉산(apovincaminic-acid)의 에틸에스테르의 제조방법 | |
| EP0483674B1 (en) | A process for producing an aliphatic amide and salts thereof | |
| US4791199A (en) | Process for antiarrhythmic 1,3-diazabicyclo[4.4.0]dec-2-en-4-ones | |
| EP0058070A2 (en) | Process for preparing pirbuterol | |
| SU622398A3 (ru) | Способ получени производных оксима или их солей | |
| US3898285A (en) | Novel enaminosulfoxides and a process for their preparation | |
| JP2513258B2 (ja) | 新規なα,β−不飽和ケトン化合物 | |
| US4173707A (en) | Cyclopentanol derivatives | |
| KR820001386B1 (ko) | 치환 이미다졸의 제조방법 | |
| JPS626719B2 (ru) | ||
| Taub et al. | Imido Esters. I. The Course of the Reaction Between Phthalic Anhydride and Caprolactam | |
| SU535295A1 (ru) | Способ получени ацил-карбоксиалканоилперекисей | |
| SU929642A1 (ru) | Способ получени @ , @ '-дизамещенных производных селенофена | |
| US4701541A (en) | Medroxalol intermediates |